Attune Medical Announces Non-Exclusive Distribution Agreement with Gentherm to Provide Blanketrol® III Heat Exchangers to ensoETM Users
- Adopters of Attune's ensoETM device can acquire Gentherm's Blanketrol III through a bundled disposable purchase option
- Attune offers a 90-day evaluation program for the Blanketrol III
- ensoETM's internal placement allows for patient access during surgery and administration of fluids and medications
- None.
Adopters of Attune’s ensoETM proactive esophageal cooling device can use a Bundled Disposable Purchase Option to acquire Gentherm’s Blanketrol® III through Attune.
Attune Medical’s ensoETM is a single use thermal regulating device that is placed in the esophagus and connected to an external heat exchange unit such as the Blanketrol III, creating a closed-loop system for heat transfer to increase or decrease patient temperature. Its placement in the esophagus, with proximity to blood flow from the heart and great vessels, allows highly efficient heat transfer. Unlike surface warming devices, ensoETM‘s internal placement doesn't impede patient access during surgery and allows gastric decompression and administration of fluids and medications.
The Blanketrol III is used to lower or to raise a patient’s temperature and/or maintain a desired temperature through conductive heat transfer.
“We were happy to take advantage of this distribution option, as it was an attractive route to avoid the need for capital funds and begin treating our high patient volume as quickly as possible,” noted Dr. Mayank Sardana, Cardiac Electrophysiologist at HonorHealth in
“Gentherm’s Blanketrol III System is one of the more popular options to use with the ensoETM, which is experiencing rapid uptake amongst a broad range of clinicians,” commented Jay Istvan, Attune’s president and CEO. “We are pleased to provide our customers with the convenience of an additional method to obtain a Blanketrol III for use with the ensoETM system which may offer a faster route to provide this therapy.”
“The ensoETM is an innovative approach to targeted temperature management and we are pleased that we can collaborate with Attune to provide our reliable and trusted Blanketrol III system to deliver a full-service solution for health care providers,” commented Steve Fletcher, Senior Vice President & General Manager, Gentherm Medical.
About Gentherm
Gentherm (NASDAQ: THRM) is the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in
About Attune Medical
Attune Medical’s novel medical device technology simplifies access to the patient’s core to efficiently control temperature and is the only device FDA-cleared for use in the esophagus for patient temperature management. The ensoETM device is used in critical care units, operating rooms, and emergency departments for the intentional modulation of patient core temperature and can be rapidly placed by most trained healthcare professionals.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230830615921/en/
Lisa Owens, lisammowens@gmail.com, 210.601.6647
Source: Attune Medical
